YZJ-4729 Shows Promise in Phase Ⅱ Trial for Postoperative Pain Relief
A Phase Ⅱ study is evaluating the efficacy and safety of YZJ-4729 in patients with moderate to severe acute pain after abdominal surgery.
Asset / Drug
Drug and asset intelligence for YZJ-4729 with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.